天然产物研究与开发 ›› 2020, Vol. 32 ›› Issue (增刊2): 86-92.

• 研究简报 • 上一篇    下一篇

B-Raf (V600E)激酶IIB型抑制剂的三维定量构效关系

张聪聪1,张雯2,龙映庭1,谢惠定1,邱开雄1*


  

  1. 1昆明医科大学药学院,昆明650500;2甘肃省第三人民医院,兰州 730000

  • 出版日期:2020-12-09 发布日期:2020-12-09
  • 基金资助:
    云南省科技厅-昆明医科大学联合专项(2017FE468-023)

Three dimensional quantitative structure activity relationship of B-Raf (V600E) kinase ⅡB inhibitor

ZHANG Cong-cong1,ZHANG Wen2,LONG Ying-ting1,XIE Hui-ding1,QIU Kai-xiong1*#br#

#br#
  

  1. 1School of Pharmacy,Kunming Medical University,Kunming 650500,China; 2The Third People′s Hospital of Gansu Province,Lanzhou 730000,China

  • Online:2020-12-09 Published:2020-12-09

摘要:

为实现B-Raf (V600E)激酶IIB型抑制剂的虚拟筛选和研发结构新颖的抗癌药物提供重要研究基础,采用比较分子相似性指数分析法(CoMSIA)对一系列B-Raf (V600E)激酶IIB型抑制剂进行了三维定量构效关系的研究,并对所得CoMSIA模型三维等势图进行分析。实验结果显示,CoMSIA模型的交叉验证系数q2 = 0.406,非交叉验证系数r2ncv= 0.996。本研究表明,增大嘧啶环处基团的体积,降低苯环上基团的电负性,有利于活性的提高;分子中的氨基(-NH2)和亚氨基(-NH)为氢键供体基团,羰基(>C=O)和磺酰基(-SO2-)为氢键受体基团,是活性关键基团;吡啶环中的氮原子会降低化合物的活性。

关键词: B-Raf (V600E)激酶IIB型抑制剂, 比较分子相似性指数分析法, 结构改造, 药效团模型

Abstract:

To realize the virtual filtering of B-Raf (V600E) kinase IIB-type inhibitors and provide an important research basis for the development of novel anticancer drugs.We use comparative molecular similarity index analysis (CoMSIA) to study a series of B-Raf (V600E) kinase IIB-type inhibitors in three-dimensional quantitative structure-activity relationship,and the three-dimensional equipotential diagram of the obtained CoMSIA model was analyzed.The experimental results show that the cross validation coefficient of CoMSIA model q2 = 0.406,and the non cross validation coefficient of CoMSIA model r2ncv= 0.996.The results suggested that increasing the volume of groups in pyrimidine ring and decreasing the electronegativity of groups in benzene ring are beneficial to the improvement of activity,amino (-NH2) and imino (-NH) in the molecule are hydrogen bond donor groups,carbonyl (>C=O) and sulfonyl (-SO2-) are hydrogen bond receptor groups,which are the key active groups,and nitrogen atom in pyridine ring will reduce the activity of the compound.

Key words: B-Raf (V600E) kinase IIB-type inhibitor, comparative molecular similarity index analysis, structural modification, pharmacophore model

中图分类号:  R914.2